Evaluation of Lymphoma Prognosis and Survivorship in Recently Diagnosed Patients, LEO Study | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluation of Lymphoma Prognosis and Survivorship in Recently Diagnosed Patients, LEO Study	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Enrolling by invitation	Not stated	2026-07-13		NCT04996706

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Emory University	393
M.D. Anderson Cancer Center	1145
Mayo Clinic	970
National Cancer Institute (NCI)	3015
University of Iowa	102
University of Miami	277
University of Rochester	189
Washington University School of Medicine	475
Weill Medical College of Cornell University	276

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Emory St. Joseph's Hospital	Atlanta	United States	1
Emory University Hospital Midtown	Atlanta	United States	246
Mayo Clinic	Rochester	United States	68
Mayo Clinic in Arizona	Scottsdale	United States	191
Mayo Clinic in Florida	Jacksonville	United States	224
MD Anderson Cancer Center	Houston	United States	589
University of Iowa	Iowa City	United States	284
University of Miami: Sylvester Comprehensive Cancer Center	Miami	United States	1
University of Rochester Medical Center	Rochester	United States	162
Washington University School of Medicine in St. Louis	St Louis	United States	31
Weill Cornell Medical College	New York	United States	58
Winship Cancer Institute of Emory University	Atlanta	United States	45